l.Kanitakis J.Anatomy, histology and immunohistochemistry of normal human skin. Eur IDermatol2002;12:390-399. 2. Montagna W, Parakkal PF. The Structure and Function of the Skin. 3rd ed. New York, NY:Academic Press; 1974. 3. Montagna W, Freedberg 1M, eds. Cutaneous biology 1950-1975. IInvest DermatolI976;67: 1-230. 4. Murphy GF. Histology of the skin. In: Elder DE, Elenitsas R, Johnson BL Jr, Murphy GF, eds. Lever's Histopathology of the Skin. 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005. 5. Visinoni AE, Lisboa-Costa T, Pagnan NA, et al. Ectodermal dysplasias: Clinical and molecular review. Am IMed Genet A 2009;149A: 1980-2002. 6. Breathnach AS. Embryology of human skin. A review of ultrastructural studies. IInvest Dermatol 1971 ;57: 133-143. 7. Holbrook KA, Odland GF. The fine structure of developing human epidermis: Light, scanning and transmission elec-tron microscopy of the periderm. IInvest Dermatol1975;65: 16-38. 8. Tamiolakis D, Papadopoulos N, Lambropoulou M, et al. Ber-H2 Immunohistochemical staining of human fetal tissue. lru ] Biol Sci 2005;1:135-140. 9. Hentula M, Peltonen J, Peltonen S. Expression profiles of cell-cell and cell-matrix junction proteins in developing human epidermis. Arch Dermatol Res 2001 ;293:259-267. 10. Smith LT, Sakai LY,Burgeson RE, et al. Ontogeny of struc-tural component at the dermal-epidermal junction in human embryonic and fetal skin: The appearance of anchoring fibrils and type VII collagen.] Invest Dermatol 1988;90:480-485. 11. Sagebiel RW, Rorsman H. Ultrastructural identification of melanocytes in early human embryos [abstract].] Invest Dermatol 1970;54:96. 12. Foster CA, Holbrook KA, Farr AG. Ontogeny of Langer-hans cells in human embryonic and fetal skin: Expression of HLA-DR and OKT-6 determinants.] Invest Dermatol1986; 86:240-243. 13. Foster CA, Holbrook KA. Ontogeny of Langerhans cells in human embryonic and fetal skin: Cell densities and phe-notypic expression relative to epidermal growth. Am] Anat 1989;184:157-164. 14. Winkelmann RK, Breathnach AS. The Merkel cell.] Invest Dermatol1973;60:2-15. 15. Moll R, Moll I, Franke WW. Identification of Merkel cells in human skin by specific cytokeratin antibodies: Changes of cell density and distribution in fetal and adult plantar epi-dermis. Differentiation 1984;28: 136-154. 16. Moll I, Lane AT, Franke ww, et al. Intraepidermal for-mation of Merkel cells in xenografts of human fetal skin. ] Invest Dermatol 1990;94:359-364. 17. Polakovicoca S, Seidenberg H, Mikusova R, et al. Merkel cell-review on developmental, functional and clinical aspects. Bratisl Lek Listy 2011;112:80-87. 18. Boot PM, Rowden G, Walsh N. The distribution of Merkel cells in human fetal and adult skin. Am ] Dermatopathol 1992; 14:391-396. 19. Breathnach AS. Development and differentiation of dermal cells in man.] Invest Dermatol 1978;71:2-8. 20. Smith LT, Holbrook KA, Madri JA. Collagen types I, III, and V in human embryonic and fetal skin. Am] Anat 1986; 175: 507-521. 21. Mehregan AH, Hashimoto K, Mehregan DA, et al. Normal structure of the skin. In: Mehregan AH, Hashimoto K, Meh-regan DA, Mehregan DR, eds. Pinkus' Guide to Dermatohis-topathology. 6th ed. Norwalk, CT: Appleton &Lange; 1995. 22. Lavker RM, Sun TT, Oshima H, et al. Hair follicle stem cells.] Investig Dermatol Symp Proc 2003;8:28-38. 23. Matsuzaki T, Yoshizato K.Role of hair papilla on induction and regeneration processes of hair follicles. Wound Repair Regen 1998;6:524-530. 24. Downig DT, Stewart ME, Strauss JJ.Biology of sebaceous glands. In: Fitzpatrick TB, EisenAZ, Wolff K, Freedberg 1M, Austen KF, eds. Dermatology in General Medicine. Vol 1. 3rd ed. New York, NY: McGraw-Hill; 1987:185-190. 25. Muller M, Jasmin JR, Monteil RA, et al. Embryology of the hair follicle. Early Hum Dev 1991 ;26: 159-166. 26. Hashimoto K, Gross BG, Lever WF. The ultrastructure of the skin of human embryos. I. The intraepidermal eccrine sweat duct.] Invest Dermatol1965;45:139-151. 27. Montagna W. Embryology and anatomy of the cutaneous adnexa.] Cutan Pathol 1984;11:350-351. 28. Hosoi J, Murphy GF, Egan CL, et al. Regulation of Lang-erhans cell function by nerves containing calcitonin gene-related peptide. Nature 1993;363: 159-163.29. Koster M. p63 in skin development and ectodermal dyspla-sias.] Invest Dermatol 2010; 130:2352-2358. 30. Ishiko A, Matsunaga Y,Masunaga T, et al. Immunomolecular mapping of adherens junction and desmosomal components in normal human epidermis. Exp Dermatol2003;12:747-754. 31. Wolff K, Schreiner E. Ultrastructural localization of pem-phigus autoantibodies within the epidermis. Nature 1971; 229:59-61. 32. Stanley JR, Klaus-Kovtun V,Sampaio SAP.Antigenic speci-ficity of fogo selvagem autoantibodies is similar to North American pemphigus foliaceus and distinct from pemphi-gus vulgaris autoantibodies.] Invest Dermatol1986;87: 197-201. 33. Val-BernaIJF, Diego C, Rodriquez-Villar D, et al. The nipple-areola complex epidermis: A prospective systematic study in adult autopsies. Am] Dermatopathol2010;32:787-793. 34. Toker C. Clear cells of the nipple epidermis. Cancer 1970; 25:601-610. 35. Willman JH, Golitz LE, Fitzpatrick JE. Clear cells of Toker in accessory nipples.] Cutan Pathol 2003;30:256-260. 36. Kumarasinghe SP, Chin GY, Kumarasinghe MP. Clear cell papulosis of the skin: A case report from Singapore. Arch Pathol Lab Med 2004;128:e149-e152. 37. Marucci G, Betts CM, Golouh R, et al. Toker cells are prob-ably precursors of Paget cell carcinoma: A morphological and ultrastructural description. VirchowsArch 2002;441: 117-123. Epub 2002 Feb 01. 38. Kuo TT, Chan HL, Hsueh S. Clear cell papulosis of the skin. A new entity with histogenetic implications for cutane-ous Paget's disease. Am] Surg PathoI1987;1l:827-834. 39. Tschen JA, McGavran MH, Kettler AH. Pagetoid dyskerato-sis: A selective keratinocytic response.] Am Acad Dermatol 1988;19:891-894. 40. Kim YC, Mehregan DA, Bang D. Clear cell papulosis: An immunohistochemical study to determine histogenesis. ] Cutan Pathol 2002;29: 11-14. 41. Elias PM. Epidermal lipids, barrier function, and desquama-tion.] Invest Dermatol1983;80:44s-49s. 42. Zirra AM. The functional significance of the skin's stratum lucidum. Morphol Embryol 1976;22:9-12. 43. Katz SI. The epidermal basement membrane zone-structure, ontogeny, and role in disease.] Am Acad Dermatol 1984; 11: 1025-1037. 44. Foidart JM, Bere EW Jr, Yaar M, et al. Distribution and immunoelectron microscopic localization of laminin, a non-collagenous basement membrane glycoprotein. Lab Invest 1980;42:336-342. 45. Smith JB, Taylor TB, Zone JJ.The site of blister formation in dermatitis herpetiformis is within the lamina lucida.] Am Acad Dermatol1992;27:209-213. 46. Leblond CP, Inoue S. Structure, composition, and assembly of basement membrane. Am] Anat 1989;185:367-390. 47. Woodley DT, Burgeson RE, Lunstrum G, et al. Epidermol-ysis bullosa acquisita antigen is the globular carboxyl ter-minus of type VII procollagen.] Clin Invest 1988;81 :683-687. 48. Shimizu H, McDonald IN, Gunner DB, et al. Epidermolysis bullosa acquisita antigen and the carboxy terminus of type VII collagen have a common immunolocalization to anchor-ing fibrils and lamina densa of basement membrane. Br ] Dermatol1990;122:577-585. 49. Scott GA, Cassidy L, Tran H, et al. Melanocytes adhere to and synthesize laminin-5 in vitro. Exp DermatolI999;8:212-22l. 50. Tarnowski WM. Ultrastructure of the epidermal melanocyte dense plate.] Invest DermatolI970;55:265-268. 51. Seiberg M. Keratinocyte-melanocyte interactions during melanosome transfer. Pigment Cell Res 2001; 14:236-242. 52. Barral DC, Seabra MC. The melanosome as a model to study organelle motility in mammals. Pigment Cell Res 2004;17:111-118. 53. Murphy GF. Structure, function and reaction patterns. In: Murphy GF, ed. Dermatopathology. Philadelphia, PA: WB Saunders; 1995. 54. Gown AM, VogelAM, Hoak 0,et al. Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. Am] PatholI986;123: 195-203. 55. Kanitakis ]. Immunohistochemistry of normal skin. In: Kanitakis J, Vassileva S, Woodley 0,eds. Diagnostic Immu-nohistochemistry of the Skin. An Illustrated Text. London, UK: Chapman &Hall Medical; 1998:38-5l. 56. Birbeck NS, Breathnach AS, Everall JD. Anelectron micro-scope study of basal melanocytes and high-level clear cells in vitiligo. ] Invest Dermatol 1961;37: 51-64. 57. Niebauer G, Krawczyk W, Wilgram GF. The Langerhans cell organelle in Letterer Siwe's disease. Arch Klin Exp Dermatol 1970;239: 125-137. 58. Halata Z, Grim M, Baumann KI. The Merkel cell: Morphol-ogy, developmental origin, function. Cas Lek Cesk 2003; 142:4-9. 59. Halata Z, Grim M, Bauman KI. Friedrich Sigmund Merkel and his "Merkel cell," morphology, development, and physi-ology: Review and new results. Anat Rec A Discov Mol Cell Evol Biol 2003;271:225-239. 60. Tachibana T, Nawa T.Recent progress in studies on Merkel cell biology. Anat Sci Int 2002;77:26-33. 6l. Santa Cruz OJ, Bauer EA. Merkel cells in the outer follicu-lar sheath. Ultrastruct PatholI982;3:59-63. 62. Camisa C, Weissmann A. Friedrich Sigmund Merkel Part II. The cell. Am] DermatopathoI1982;4:527-535. 63. Gu J, Polak JM, Van Noorden S, et al. Immunostaining of neuron-specific enolase as a diagnostic tool for Merkel cell tumors. Cancer 1983;52: 1039-1043. 64. Leff EL, Brooks JSJ, Trojanowski JQ. Expression of neurohla-ment and neuron-specific enolase in small cell tumors of skin using immunohistochemistry. Cancer 1985;56:625-631. 65. Rosen ST, Gould VE, Salwen HR, et al. Establishment and characterization of a neuroendocrine skin carcinoma cell line. Lab Invest 1987;56:302-312. 66. van Muijen GNP, Ruiter OJ, Warnaar SO. Intermediate fila-ments in Merkel cell tumors. Hum PatholI985;16:590-595. 67. Wang NP, Zee S, Zarbo RJ, et al. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 1995;3:99-107. 68. Moll I, Kuhn C, Moll R.Cytokeratin 20 is a general marker of cutaneous Merkel cells while certain neuronal proteins are absent.] Invest Dermatol 1995; 104:910-915. 69. Headington JT.Transverse microscopic anatomy of the human scalp. A basis for a morphometric approach to disor-ders of the hair follicle. Arch Dermatol 1984; 120:449-456.70. de Viragh PA. The 'mantle hair of Pinkus.' A review on the occasion of its centennial. Dermatology 1995;191:82-87. 71. Alonso LC, Rosenfield RL. Molecular genetic and endo-crine mechanisms of hair growth. Horm Res 2003;60: 1-13. 72. Nakagawa H, Imokawa G. Characterization of melanogene-sis in normal human epidermal melanocytes by chemical and ultrastructural analysis. Pigment Cell Res 1996;9: 175-178. 73. Jimbow K, Ishida 0,Ito S, et al. Combined chemical and electron microscopic studies of pheomelanosomes in human red hair.] Invest Dermatol 1983 ;81:506-51l. 74. Biasiolo M, Bertazzo A, Costa Cv, et al. Correlation between tryptophan and hair pigmentation in human hair. Adv Exp Med BioI 1999;467:653-657. 75. Burchill SA, Ito S, Thody A]. Effects of melanocyte-stimulating hormone on tyrosinase expression and mela-nin synthesis in hair follicular melanocytes of the mouse. ] EndocrinoI1993;137:189-195. 76. Smith KR Jr. The Haarscheibe. ] Invest Dermatol 1977; 69:68-74. 77. Baron DA, Briggman JV, Spicer SS. Tubulocisternal endo-plasmic reticulum in human eccrine sweat glands. Lab Invest 1984;51 :233-243. 78. Sbarbati A, Osculati A, Morroni M, et al. Electron spectro-scopic imaging of secretory granules in human eccrine sweat glands. Eur] Histochem 1994;38:327-330. 79. Schaumburg-Lever G, Lever WF. Secretion from human apocrine glands: An electron microscopic study.] Invest Der-matolI975;64:38-4l. 80. Sato K, Leidal R, Sato F. Morphology and development of an apoeccrine sweat gland in human axillae. Am] Physiol 1987;252:RI66-RI80. 81. Kamada A, Saga K, Jimbow K.Apoeccrine sweat duct obstruction as a cause for Fox-Fordyce disease. ] Am Acad Dermatol2003;48:453-455. 82. Reed RJ, Ackerman AB. Pathology of the adventitial der-mis. Anatomic observations and biologic speculations. Hum PatholI973;4:207-217. 83. Meigel WN, Gay S, Weber L. Dermal architecture and col-lagen type distribution. Arch Dermatol Res 1977;259:1-10. 84. Junqueira LC, Montes GS, Martins JE, et al. Dermal colla-gen distribution. A histochemical and ultrastructural study. Histochemistry 1983;79:397-403. 85. Sorrell JM, Caplan AI. Fibroblast heterogeneity: More than skin deep.] Cell Sci 2004; 117:667-675. 86. McNeal JE. Scleroderma and the structural basis of skin compliance. Arch DermatolI973;107:699-705. 87. Nestle FO, Nickoloff B]. A fresh morphological and functional look at dermal dendritic cells. ] Cutan Pathol 1995;22:385-393. 88. Narvaez 0,Kanitakis J, Faure M, et al. Immunohistochemi-cal study of CD34-positive dendritic cells of human dermis. Am] DermatopatholI996;18:283-288. 89. Kanitakis]. Immunohistochemistry of normal human skin. Eur] DermatolI998;8:539-547. 90. Nickoloff BJ, Griffiths CEo Not all spindled-shaped cells embedded in a collagenous stroma are fibroblasts: Recog-nition of the "collagen-associated dendrophage." ] Cutan PatholI990;17:252-254. 91. Headington JT.The dermal dendrocyte. Adv Dermatol 1986; 1:159-17l. 92. Headington JT, Cerio R.Dendritic cells and the dermis: 1990. Am] DermatopatholI990;12:217-220. 93. Sepulveda-Merrill C, Mayall S, Hamblin AS, et al. Antigen-presenting capacity in normal human dermis is mainly sub-served by CDla+ cells. Br] DermatolI994;131:15-22. 94. Meunier L, Gonzalez-Ramos A, Cooper KD. Heterogeneous populations of class II MHC+ cells in human dermal cell sus-pensions. Identification of a small subset responsible for potent dermal antigen-presenting cell activity with features analogous to Langerhans cells.] Immunol. 1993;151:4067-4080. 95. Walls AF, Jones DB, Williams JH, et al. Immunohistochemi-cal identification of mast cells in formaldehyde-fixed tissue using monoclonal antibodies specific for tryptase. ] Pathol 1990; 162: 119-126. 96. Arber DA, Tamayo R, Weiss LM. Paraffin section detec-tion of the c-kit gene product in human tissues: Value in the diagnosis of mast cell disorders. Hum Pathol 1998;29:498-504. 97. Longley BJ, Reguera MJ, Ma Y.Classes of c-KIT activat-ing mutations: Proposed mechanisms of action and impli-cations for disease classification and therapy. Leuk Res 2001;25:571-576. 98. Metcalfe DD,Akin C. Mastocytosis: Molecular mechanisms and clinical disease heterogeneity. Leuk Res 2001;25:577-582. 99. Valent P, Horny HP, Escribano L, et al. Diagnostic criteria and classification of mastocytosis: A consensus proposal. Leuk Res 2001 ;25:603-625. 100. Dotto JE, Glusac EJ. p63 is a useful marker for cutane-ous spindle cell squamous cell carcinoma. ] Cutan Pathol 2006;33:413-417. 101. Ryan TJ, Mortimer PS, Jones RL. Lymphatics of the skin. Neglected but important. Int] Dermatol 1986;25:411-419. 102. Johnson BL, Honig P],Jaworsky C, eds. Pediatric Dermato-pathology Newton, MA: Butterworth-Heinemann; 1994. 103. Pochi PE, Strauss JS, Downing DT. Age-related changes in sebaceous gland activity.] Invest DermatolI979;73: 108-111. 104. Klaus S. Functional differentiation of white and brown adi-pocytes. Bioessays 1997;19:215-223. 105. Klaus S. Adipose tissue as a regulator of energy balance. Curr Drug Targets 2004;5:241-250. 106. Fenske NA, Lober CWo Structural and functional changes of normal aging skin. ] Am Acad Dermatol 1986;15: 571-585. 107. Smith L. Histopathologic characteristics and ultrastructure of aging skin. Cutis 1989;43:414-424. 108. Patterson JAK. Structural and physiologic changes in the skin with age. In: Patterson JAK, ed. Aging and Clinical Practice: Skin Disorders, Diagnosis and Treatment. New York, NY: Igaku-Shoin; 1989. 109. Kurban RS, Bhawan J. Histologic changes in skin associated with aging.] Dermatol Surg Oncol 1990; 16:908-914. 110. Montagna W, Carlisle K. Structural changes in ageing skin. Br] DermatolI990;122:61-70. Ill. Sauder DN. Effect of age on epidermal immune function. Dermatol Clin 1986;4:447-454. 112. Lavker RM, Zheng PS, Dong G. Morphology of aged skin. Clin Geriatr Med 1989;5:53-67. 113. Balin AK, Pratt LA. Physiological consequences of human skin aging. Cutis 1989;43:431-436.114. BologniaJL.Agingskin.Am] Med 1995;98:99S-103S. 115. Cerimele D, Celleno L, Serri F.Physiological changes in ageing skin. Br] DermatolI990;122:13-20. 116. Rongioletti F, Rebora A. Fibroelastolytic patterns of intrinsic skin aging: Pseudoxanthoma-elasticum-like papillary dermal elastolysis and white fibrous papulosis of the neck. Derma-tology 1995; 191: 19-24. 117. Mondragon G, Nygaard F.Routine and special procedures for processing biopsy specimens of lesions suspected to be malignant melanomas. Am ] Dermatopathol 1981;3: 265-272. 118. Plumb SJ, Argenyi ZB, Stone MS, et al. Cytokeratin 5/6 immunostaining in cutaneous adnexal neoplasms and meta-static adenocarcinoma. Am ] Dermatopathol 2004;26: 447-451. 119. Tellechea 0,Reis JP, Domingues JC, et al. Monoclonal anti-body Ber EP4 distinguishes basal-cell carcinoma from squa-mous-cell carcinoma of the skin. Am] Dermatopathol 1993; 15:452-455. 120. Krahl D, Sellheyer K. Monoclonal antibody Ber-EP4 reli-ably discriminates between microcystic adnexal carcinoma and basal cell carcinoma. ] Cutan Pathol 2007;34: 782-787. 121. Schaumburg-Lever G, Metzler G, Kaiserling E. Ultrastruc-turallocalization of HMB-45 binding sites. ] Cutan Pathol 1991; 18:432-43 5. 122. Magro CM, Crowson AN, Mihm MC Jr. Unusual variants of malignant melanoma. Mod Pathol 2006; 19:541-S70. 123. Soyer HP. Ki 67 immunostaining in melanocytic skin tumors. Correlation with histologic parameters. ] Cutan Pathol 1991; 18:264-272. 124. Nasr MR, El-Zammar 0.Comparison ofpHH3, Ki-67, and survivin immunoreactivity in benign and malignant melano-cytic lesions. Am] Dermatopathol 2008;39: 117-122. 125. Helm K, Findeis-Hosey J. Immunohistochemistry of pig-mented actinic keratoses, actinic keratoses, melanomas in situ and solar lentigines with Melan-A.] Cutan Pathol 2008;35: 931-934. 126. Pantanowitz L, Pinkus GS, Dezube BJ, et al. HHV8 is not limited to Kaposi's sarcoma. Mod Pathol 2005;18:1148-1150. 127. Patel RM, Goldblum JR, Hsi ED. Immunohistochemical detection of human herpes virus-8 latent nuclear antigen-I is useful in the diagnosis of Kaposi sarcoma. Mod Pathol 2004;17:456-460. 128. Altman DA, Nickoloff BJ, Fivenson DP. Differential expres-sion of factor XIIIa and CD34 in cutaneous mesenchymal tumors.] Cutan PatholI993;20:154-158. 129. Scholzen T, Gerdes J. The Ki-67 protein: From the known and the unknown.] Cell Physiol 2000; 182:311-322. 130. LiLX, Crotty KA, McCarthy SW, et al. A zonal comparison of MIB 1-Ki67 immunoreactivity in benign and malignant melanocytic lesions. Am] Dermatopathol2000;22:489-495. 131. Abdelsayed RA, Guijarro- Rojas M, Ibrahim NA, et al. Immunohistochemical evaluation of basal cell carcinoma and trichoepithelioma using Bcl-2, Ki67, PCNA and P53. ] Cutan Pathol2000;27:169-175. 132. Talghini S, Halimi M, Baybordi H. Expression of P27, Ki67 and P53 in squamous cell carcinoma, actinic keratosis and Bowen disease. Pak] Biol Sci 2009;12:929-933.  